CHU de Tours-Hopital Bretonneau

Tours 37044

1 studies enrolling now · 6 studies all time

What they study most

Acute Myeloid Leukemia, Aggressive B-cell Non-Hodgkin Lymphoma (aNHL), DLBCL, FL, High-grade B-cell Lymphoma (HGBCL), Indolent B-cell Non-Hodgkin Lymphoma (iNHL), MCL, Marginal Zone Lymphoma (MZL), Metastatic Head and Neck Cancer, Multiple Myeloma, Primary Mediastinal Large B-cell Lymphoma (PMBCL), Recurrent Head and Neck Cancer

Studies at this site

• A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 — Recruiting now
• First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma — Running, not enrolling
• Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307) — Completed
• Pembrolizumab + Epacadostat vs Pembrolizumab + Placebo in Recurrent or Progressive Metastatic Urothelial Carcinoma — Completed
• A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia — Completed
• Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma — Completed